Nuclear medicine equipment utilize radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnosis and treat various diseases. These equipment create images by capturing the radiation from these radioactive medicines. This technique is used for early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine immediate response to therapeutic interventions. Research Beam Model: Research Beam Product ID: 1088904 5370 USD New
Nuclear Medicine Equipment by Product Type [SPECT (Standalone and Hybrid), and PET (Standalone and Hybrid)], Application (Neurology, Oncology, Cardiology, and Others), and End User (Hospitals, Imaging Centers, and Academic & Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022
 

Nuclear Medicine Equipment by Product Type [SPECT (Standalone and Hybrid), and PET (Standalone and Hybrid)], Application (Neurology, Oncology, Cardiology, and Others), and End User (Hospitals, Imaging Centers, and Academic & Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Nuclear Medicine Equipment by Product Type [SPECT (Standalone and Hybrid), and PET (Standalone and Hybrid)], Application (Neurology, Oncology, Cardiol

Category : Healthcare
Published On : February  2017
Pages : 170

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Nuclear medicine equipment utilize radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnosis and treat various diseases. These equipment create images by capturing the radiation from these radioactive medicines. This technique is used for early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine immediate response to therapeutic interventions.

The global nuclear medicine equipment market is estimated to reach $2,647 million by 2022 from $2,012 million in 2015, growing at a CAGR of 3.9% from 2016 to 2022. Increase in prevalence of cancer, heart-related diseases, and neurological disorders has given rise to the importance of early disease diagnosis, which is expected to positively impact the market growth. The nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in adoption of nuclear medicine equipment, and emergence of innovative & advanced equipment. However, high cost of these equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth.

The nuclear medicine equipment market is segmented based on product, application, end user, and geography. Based on product, the market is bifurcated into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). SPECT is further segmented into standalone and hybrid SPECT, while PET into standalone and hybrid PET. By application, the market is categorized into cardiology, neurology, oncology, and others. Based on end user, it is classified into hospitals, imaging centers, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).

The key players in the industry have adopted product launch as their key developmental strategy to expand their market foothold. For instance, in November 2016, Philips launched an advanced visual analysis and quantification platform called IntelliSpace Portal 9.0., which assists radiologists to diagnose and monitor the treatment of neurological diseases, such as multiple sclerosis and dementia.

Key market benefits

  • This report provides a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
  • Market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to product type, application, end user, and geography.
  • In-depth analysis based on geography helps in understanding the regional market to assist in strategic business planning.
  • The recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Key market segments

By Product

  • Single-Photon Emission Computed Tomography (SPECT)
    • Standalone
    • Hybrid
  • Positron Emission Tomography (PET)
    • Standalone
    • Hybrid

By Application

  • Neurology
  • Oncology
  • Cardiology
  • Others

By End User

  • Hospitals
  • Imaging Centers
  • Academic & Research Institutes

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • Republic of South Africa
    • Argentina
    • Rest of LAMEA

The key players in the global nuclear medicine equipment market include:

  • General Electric Company
  • Koninklijke Philips N.V.
  • Siemens Aktiengesellschaft
  • Digirad Corporation
  • Mediso Medical Imaging Systems, Ltd.
  • Toshiba Corporation
  • Bozlu Holding
  • Neusoft Corporation
  • Compañía Mexicana de Radiología CGR, S.A de C.V.
  • SurgicEye GmbH

The other players include (companies not profiled in the report):

  • CMR Naviscan Corporation
  • DDD-Diagnostic A/S
  • Positron Corporation
  • TeraRecon, Inc.

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITIONS AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. GOVERNMENT REGULATIONS

3.3.1. U.S. FDA
3.3.2. Europe CE Mark
3.3.3. Ministry of Health, Labor, and Welfare (MHLW)

3.4. REIMBURSEMENT SCENARIOS
3.5. CLINICAL TRIALS
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rise in prevalence of chronic diseases
3.6.1.2. Efficient and convenient technique
3.6.1.3. Growing awareness

3.6.2. Restraints

3.6.2.1. Budget constraints
3.6.2.2. Lack of trained professionals

3.6.3. Opportunities

3.6.3.1. Technological advancements
3.6.3.2. Development of skilled professionals

Chapter: 4 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE

4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. SPECT

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Standalone SPECT

4.3.4.1. Market size and forecast

4.3.5. Hybrid SPECT

4.3.5.1. Market size and forecast

4.4. PET

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Standalone PET

4.4.4.1. Market size and forecast

4.4.5. Hybrid PET

4.4.5.1. Market size and forecast

Chapter: 5 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION

5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. NEUROLOGY

5.3.1. Market size and forecast

5.4. ONCOLOGY

5.4.1. Market size and forecast

5.5. CARDIOLOGY

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER

6.1. OVERVIEW
6.2. MARKET SIZE AND FORECAST
6.3. HOSPITALS

6.3.1. Market size and forecast

6.4. IMAGING CENTERS

6.4.1. Market size and forecast

6.5. ACADEMIC AND RESEARCH INSTITUTES

6.5.1. Market size and forecast

Chapter: 7 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. MARKET SIZE AND FORECAST
7.3. NORTH AMERICA

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. U.S.
7.3.5. Canada
7.3.6. Mexico

7.4. EUROPE

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Germany
7.4.5. France
7.4.6. UK
7.4.7. Italy
7.4.8. Spain
7.4.9. Russia
7.4.10. Rest of Europe

7.5. ASIA-PACIFIC

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Japan
7.5.5. China
7.5.6. Australia
7.5.7. India
7.5.8. Rest of Asia-Pacific

7.6. LAMEA

7.6.1. Key market trends
7.6.2. Key growth factors and opportunities
7.6.3. Market size and forecast
7.6.4. Brazil
7.6.5. Turkey
7.6.6. Saudi Arabia
7.6.7. Republic of South Africa
7.6.8. Argentina
7.6.9. Rest of LAMEA

Chapter: 8 COMPANY PROFILES

8.1. KONINKLIJKE PHILIPS N.V.

8.1.1. Overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. SIEMENS AKTIENGESELLSCHAFT

8.2.1. Overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. GENERAL ELECTRIC COMPANY

8.3.1. Overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. DIGIRAD CORPORATION

8.4.1. Overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. MEDISO MEDICAL IMAGING SYSTEMS, LTD.

8.5.1. Overview
8.5.2. Operating business segments
8.5.3. Key strategic moves and developments

8.6. TOSHIBA CORPORATION

8.6.1. Overview
8.6.2. Operating business segments
8.6.3. Business performance

8.7. BOZLU HOLDING

8.7.1. Overview
8.7.2. Key strategic moves and developments

8.8. NEUSOFT CORPORATION

8.8.1. Overview
8.8.2. Operating business segments
8.8.3. Key strategic moves and developments

8.9. COMPAA MEXICANA DE RADIOLOGA CGR, S.A. DE C.V.

8.9.1. Overview

8.10. SURGICEYE GMBH

8.10.1. Overview
8.10.2. Key strategic moves and developments

LIST OF TABLES

TABLE 1. CLINICAL TRIALS: NUCLEAR MEDICINE EQUIPMENT MARKET, 2010-2016
TABLE 2. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 3. SPECT SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 4. SPECT SYSTEMS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 5. STANDALONE SPECT SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 6. HYBRID SPECT SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. PET SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. PET SYSTEMS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 9. STANDALONE PET SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 10. HYBRID PET SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 12. NEUROLOGY NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 13. ONCOLOGY NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 14. CARDIOLOGY NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 15. OTHER APPLICATIONS NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 16. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 17. HOSPITALS NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 18. IMAGING CENTRES NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 19. ACADEMIC & RESEARCH INSTITUTES NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 20. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 21. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 22. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 23. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 24. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 25. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 26. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 27. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 28. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 29. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 30. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 31. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 32. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 33. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 34. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 35. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 36. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 37. PHILIPS: COMPANY SNAPSHOT
TABLE 38. PHILIPS: OPERATING SEGMENTS
TABLE 39. SIEMENS: COMPANY SNAPSHOT
TABLE 40. SIEMENS: OPERATING SEGMENTS
TABLE 41. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 42. GE: OPERATING SEGMENTS
TABLE 43. DIGIRAD: COMPANY SNAPSHOT
TABLE 44. DIGIRAD: OPERATING SEGMENTS
TABLE 45. MEDISO: COMPANY SNAPSHOT
TABLE 46. MEDISO: OPERATING SEGMENTS
TABLE 47. TOSHIBA: COMPANY SNAPSHOT
TABLE 48. TOSHIBA: OPERATING SEGMENTS
TABLE 49. BOZLU HOLDING: COMPANY SNAPSHOT
TABLE 50. NEUSOFT: COMPANY SNAPSHOT
TABLE 51. NEUSOFT: OPERATING SEGMENTS
TABLE 52. CMR NAVISCAN: COMPANY SNAPSHOT
TABLE 53. SURGICEYE: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. SEGMENTATIONS
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2013-2016)
FIGURE 4. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 5. U.S. NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 6. CANADA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 7. MEXICO NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 8. GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 9. FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 10. UK NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 11. ITALY NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 12. SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 13. RUSSIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 14. REST OF EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 15. JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 16. CHINA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 17. AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 18. INDIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 19. REST OF ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 20. BRAZIL NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 21. TURKEY NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 22. SAUDI ARABIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 23. REPUBLIC OF SOUTH AFRICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 24. ARGENTINA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 25. REST OF LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY YEAR ($MILLION), 2014-2022
FIGURE 26. PHILIPS: REVENUE, BY YEAR ($MILLION)
FIGURE 27. PHILIPS: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 28. PHILIPS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 29. SIEMENS: REVENUE, BY YEAR ($MILLION)
FIGURE 30. SIEMENS: REVENUE, BY SEGMENT (%)
FIGURE 31. SIEMENS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 32. GENERAL ELECTRIC COMPANY: REVENUE, BY YEAR ($BILLION)
FIGURE 33. GENERAL ELECTRIC COMPANY: REVENUE, BY SEGMENT (%)
FIGURE 34. GENERAL ELECTRIC COMPANY: REVENUE, BY GEOGRAPHY (%)
FIGURE 35. DIGIRAD CORPORATION: REVENUE, BY YEAR ($MILLION)
FIGURE 36. DIGIRAD CORPORATION: REVENUE, BY SEGMENT (%)
FIGURE 37. FIG. 12 TOSHIBA: REVENUE, BY YEAR ($MILLION)
FIGURE 38. FIG. 13 TOSHIBA: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 39. TOSHIBA: REVENUE, BY GEOGRAPHY, 2015 (%)

Enquiry Before Buy